- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
- 10-K Annual report
- 21.1 Subsidiaries of Virologic, Inc.
- 23.1 Consent of Ernst & Young LLP, Independent Auditors
- 31.1 Certificiation of Chief Executive Officer Pursuant to Rule 13A-14(A)
- 31.2 Certificiation of Chief Financial Officer Pursuant to Rule 13A-14(A)
- 32.1 Certification of CEO and CFO Pursuant to 18 U.s.c. Section 1350
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration (Forms S-8 No. 333-43114, No. 333-89082 and No. 333-121437) pertaining to the 2000 Equity Incentive Plan, the 2000 Employee Stock Purchase Plan and 2004 Equity Incentive Plan of ViroLogic, Inc. and in the Registration Statements (Forms S-3 No. 333-65716, No. 333-70562, No. 333-86892, No. 333-102273, No. 333-102995, No. 333-103980, No. 333-121438 and No. 333-121475) and related Prospectuses of ViroLogic, Inc. of our report dated March 14, 2005, with respect to the financial statements and schedule of ViroLogic Inc., ViroLogic Inc.’s management’s assessment of the effectiveness of internal control over financial reporting, and the effectiveness of internal control over financial reporting of ViroLogic Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2004.
/s/ ERNST & YOUNG LLP
Palo Alto, California
March 14, 2005